Saturday December 7, 2019

Martin’s biotech fund to inject €39m into US drug company

Malin, the Irish biotech investment fund backed by former Elan boss Kelly Martin, will pump €39 million into an American drug company.

8th March, 2015

Malin, which intends to list on the Irish stock exchange later this month, has agreed to pay $18 million (€16.5 million) for an initial 41 per cent in Serenus Biotherapeutics. Depending on how Serenus performs, Malin will raise its shareholding in the company to 76 per cent for an additional $25 million.

Martin will become chairman of Serenus as part of the investment. Serenus is developing treatment for chronic and infectious diseases and plans to concentrate on the African...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Large public capital projects could be run through an “independent panel of international experts” as part of public spending reforms, according to the Department of Public Expenditure

Daniel Murray | 2 weeks ago

The contract covers the supply of office stationery to a range of government bodies and agencies, including the HSE, universities, hospitals, councils and schools

Michael Brennan | 2 weeks ago

Party would launch the ‘largest public house building programme that Ireland has ever seen’ and a national health service

Aiden Corkery | 2 weeks ago